GKB Ophthalmics Ltd Stock Price Today (NSE: GKB)
Fundamental Score
GKB Ophthalmics Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
GKB Ophthalmics Ltd share price today is ₹57.33, up +0.00% on NSE/BSE as of 17 February 2026. GKB Ophthalmics Ltd (GKB) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹29.99 (Cr). The 52-week high for GKB share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of -12.66% and a debt-to-equity ratio of 0.28.
GKB Ophthalmics Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
GKB Ophthalmics Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
GKB Ophthalmics Share Price: A Conservative Value Investor's Perspective
The medical equipment and supplies industry, while generally recession-resistant, demands careful evaluation of individual players. Innovation cycles are rapid, and maintaining market share requires continuous investment. This analysis focuses on the GKB Ophthalmics share price of ₹54.880001, offering a preliminary observation from a conservative value investing standpoint with a strong emphasis on capital preservation. This is an excerpt of an 80-parameter fundamental audit verified by Sweta Mishra.
A primary concern for a value investor is GKB Ophthalmics Ltd's lack of a Price-to-Earnings (PE) ratio, indicating either negative earnings or inconsistent profitability. More concerning is the Return on Capital Employed (ROCE) of -6.0%. ROCE is a crucial metric, demonstrating how effectively a company generates profits from its invested capital. A negative ROCE suggests the company is destroying value rather than creating it. This negative figure significantly undermines any potential economic moat GKB Ophthalmics might attempt to build. A strong moat, the ability to protect profits from competitors, relies on efficient capital allocation and healthy returns.
When evaluating companies, understanding their competitive landscape is key. GKB Ophthalmics Ltd operates alongside peers like Choksi Asia. Management quality plays a crucial role in the success of any business. While we are not passing judgement, it's prudent to compare
Choksi Asia's leadership team's track record of capital allocation, investor communication, and strategic vision with that of GKB Ophthalmics. A difference in these aspects could heavily influence long-term performance. Comparing to OSEL DEVICES LIMITED and Transpact Enterprises Ltd is also worth consideration.For a conservative value investor prioritizing capital safety, the negative ROCE and absence of a positive PE ratio for GKB Ophthalmics share price raises serious red flags. These indicators would warrant a deeper investigation into the underlying causes of the company's financial performance. Further due diligence is needed to understand GKB Ophthalmics' cash flow, debt levels, and long-term growth prospects before any investment decision could even be considered. Remember, this analysis is purely observational and does not constitute investment advice.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
GKB Ophthalmics Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of GKB across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Robust Profit Growth (231.15%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (15.42%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (13.24% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Conservative Debt Levels (D/E: 0.28)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (51.06%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (-12.66%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-6.00%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (2.15%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Weak Interest Coverage (-0.65x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-3.82 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 1.79%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
GKB Ophthalmics Ltd Financial Statements
Comprehensive financial data for GKB Ophthalmics Ltd including income statement, balance sheet and cash flow
About GKB (GKB Ophthalmics Ltd)
GKB Ophthalmics Ltd (GKB) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equipment & Supplies sector with a current market capitalisation of ₹29.99 (Cr). GKB Ophthalmics Ltd has delivered a Return on Equity (ROE) of -12.66% and a ROCE of -6.00%. The debt-to-equity ratio stands at 0.28, reflecting the company's capital structure. Investors tracking GKB share price can monitor key metrics including P/E ratio, promoter holding of 51.06%, and quarterly earnings growth.
Company Details
Key Leadership
Corporate Events
Latest News
GKB Share Price: Frequently Asked Questions
What is the current share price of GKB Ophthalmics Ltd (GKB)?
As of 17 Feb 2026, 10:10 am IST, GKB Ophthalmics Ltd share price is ₹57.33. The GKB stock has a market capitalisation of ₹29.99 (Cr) on NSE/BSE.
Is GKB share price Overvalued or Undervalued?
GKB share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 47.87x. Based on this relative valuation, the GKB Ophthalmics Ltd stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of GKB share price?
The 52-week high of GKB share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the GKB Ophthalmics Ltd share price?
Key factors influencing GKB share price include quarterly earnings growth (Sales Growth: 15.42%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is GKB Ophthalmics Ltd a good stock for long-term investment?
GKB Ophthalmics Ltd shows a 5-year Profit Growth of N/A% and an ROE of -12.66%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.28 before investing in GKB shares.
How does GKB Ophthalmics Ltd compare with its industry peers?
GKB Ophthalmics Ltd competes with major peers in the Medical Equipment & Supplies. Investors should compare GKB share price P/E of 0.00x and ROE of -12.66% against the industry averages to determine competitive standing.
What is the P/E ratio of GKB and what does it mean?
GKB share price has a P/E ratio of N/Ax compared to the industry average of 47.87x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is GKB performing according to Bull Run's analysis?
GKB has a Bull Run fundamental score of 29.9/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does GKB belong to?
GKB operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting GKB Ophthalmics Ltd share price.
What is Return on Equity (ROE) and why is it important for GKB?
GKB has an ROE of -12.66%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently GKB Ophthalmics Ltd generates profits from shareholders capital.
How is GKB debt-to-equity ratio and what does it indicate?
GKB has a debt-to-equity ratio of 0.28, which indicates conservative financing with low financial risk.
What is GKB dividend yield and is it a good dividend stock?
GKB offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in GKB Ophthalmics Ltd shares.
How has GKB share price grown over the past 5 years?
GKB has achieved 5-year growth rates of: Sales Growth 13.24%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in GKB and why does it matter?
Promoters hold 51.06% of GKB shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in GKB Ophthalmics Ltd.
What is GKB market capitalisation category?
GKB has a market capitalisation of ₹30 crores, placing it in the Small-cap category.
How volatile is GKB stock?
GKB has a beta of N/A. A beta > 1 suggests the GKB Ophthalmics Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is GKB operating profit margin trend?
GKB has a 5-year average Operating Profit Margin (OPM) of 2.15%, indicating the company's operational efficiency.
How is GKB quarterly performance?
Recent quarterly performance shows GKB Ophthalmics Ltd YoY Sales Growth of 15.42% and YoY Profit Growth of 231.15%.
What is the institutional holding pattern in GKB?
GKB has FII holding of 1.79% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the GKB Ophthalmics Ltd stock.